• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New therapies, new concerns: rituximab-associated lung injury.

作者信息

Lands Larry C

出版信息

Pediatr Nephrol. 2010 Jun;25(6):1001-3. doi: 10.1007/s00467-010-1476-3. Epub 2010 Mar 2.

DOI:10.1007/s00467-010-1476-3
PMID:20195643
Abstract
摘要

相似文献

1
New therapies, new concerns: rituximab-associated lung injury.新疗法，新担忧：利妥昔单抗相关的肺损伤。
Pediatr Nephrol. 2010 Jun;25(6):1001-3. doi: 10.1007/s00467-010-1476-3. Epub 2010 Mar 2.
2
[Cryptococcus neoformans meningoencephalitis in a patient treated with rituximab].[利妥昔单抗治疗的患者发生新型隐球菌性脑膜脑炎]
Med Clin (Barc). 2009 Jun 27;133(4):157-8. doi: 10.1016/j.medcli.2008.09.036. Epub 2009 Mar 5.
3
Organizing pneumonia associated with rituximab: Challenges raised by establishing causality.
Joint Bone Spine. 2008 May;75(3):260-2. doi: 10.1016/j.jbspin.2008.02.001. Epub 2008 Apr 18.
4
Late-onset neutropenia following rituximab.
Leuk Lymphoma. 2006 Jun;47(6):965-6. doi: 10.1080/10428190600649349.
5
The infectious consequences of rituximab addition to fludarabine-containing regimens.
Blood. 2006 Apr 1;107(7):3013-4. doi: 10.1182/blood-2005-10-4012.
6
FDA: Increased HBV reactivation risk with ofatumumab or rituximab.美国食品药品监督管理局：使用奥法木单抗或利妥昔单抗会增加乙肝病毒再激活风险。
JAMA. 2013 Oct 23;310(16):1664. doi: 10.1001/jama.2013.281115.
7
Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.利妥昔单抗（B细胞耗竭抗体）相关肺损伤（RALI）：1例儿科病例及文献系统综述
Pediatr Pulmonol. 2009 Sep;44(9):922-34. doi: 10.1002/ppul.20864.
8
Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy.抗CD20（利妥昔单抗）治疗期间多发性骨髓瘤的加速进展。
Ann Oncol. 1999 Oct;10(10):1249-50. doi: 10.1023/a:1008310819049.
9
Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma.在伯基特淋巴瘤患者中使用利妥昔单抗后发生的急性肿瘤溶解综合征。
Intern Emerg Med. 2008 Jun;3(2):161-3. doi: 10.1007/s11739-008-0099-1. Epub 2008 Feb 13.
10
Fatal cytokine release syndrome with chimeric anti-CD20 monoclonal antibody rituximab in a 71-year-old patient with chronic lymphocytic leukemia.一名71岁慢性淋巴细胞白血病患者使用嵌合抗CD20单克隆抗体利妥昔单抗后发生致命性细胞因子释放综合征。
J Clin Oncol. 1999 Jun;17(6):1962-3. doi: 10.1200/jco.1999.17.6.1962.

引用本文的文献

1
Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease.12例抗肿瘤药所致间质性肺疾病分析
Front Pharmacol. 2023 Aug 28;14:1218480. doi: 10.3389/fphar.2023.1218480. eCollection 2023.
2
pneumonia in non-Hodgkin's lymphoma after rituximab-based chemotherapy: a case series.基于利妥昔单抗的化疗后非霍奇金淋巴瘤患者发生肺炎：病例系列报道
Transl Cancer Res. 2022 Jul;11(7):2291-2298. doi: 10.21037/tcr-22-1216.
3
Exploration and Evaluation of Therapeutic Efficacy of Drug-Free Macromolecular Therapeutics in Collagen-Induced Rheumatoid Arthritis Mouse Model.

本文引用的文献

1
Cryptogenic organizing pneumonia after rituximab therapy for presumed post-kidney transplant lymphoproliferative disease.利妥昔单抗治疗疑似肾移植后淋巴组织增生性疾病后发生的隐源性机化性肺炎。
Pediatr Nephrol. 2010 Jun;25(6):1163-7. doi: 10.1007/s00467-010-1447-8. Epub 2010 Feb 6.
2
Severe respiratory adverse events associated with rituximab infusion.与利妥昔单抗输注相关的严重呼吸道不良事件。
Pediatr Nephrol. 2010 Jun;25(6):1193. doi: 10.1007/s00467-009-1408-2. Epub 2009 Dec 19.
3
Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.
无药物高分子治疗药物在胶原诱导的类风湿关节炎小鼠模型中的疗效探索与评估。
Macromol Biosci. 2020 May;20(5):e1900445. doi: 10.1002/mabi.201900445. Epub 2020 Mar 20.
4
Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.无药物大分子治疗学：结构对 Raji B 细胞凋亡诱导的影响。
J Control Release. 2017 Oct 10;263:139-150. doi: 10.1016/j.jconrel.2016.12.025. Epub 2016 Dec 24.
5
Design of smart HPMA copolymer-based nanomedicines.基于聚甲基丙烯酸-N-羟丙酯共聚物的智能纳米药物设计。
J Control Release. 2016 Oct 28;240:9-23. doi: 10.1016/j.jconrel.2015.10.003. Epub 2015 Oct 3.
6
Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.无药大分子疗法——聚合物纳米药物的新范例
Biomater Sci. 2015 Jul;3(7):908-22. doi: 10.1039/C4BM00442F.
7
Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.通过寡核苷酸杂交诱导细胞表面杂交纳米复合物的自组装诱导细胞凋亡。
ACS Nano. 2014 Jan 28;8(1):719-30. doi: 10.1021/nn4053827. Epub 2013 Dec 10.
8
Anti-CD20 multivalent HPMA copolymer-Fab' conjugates for the direct induction of apoptosis.抗 CD20 多价 HPMA 共聚物-Fab' 缀合物可直接诱导细胞凋亡。
Biomaterials. 2012 Oct;33(29):7174-81. doi: 10.1016/j.biomaterials.2012.06.024. Epub 2012 Jul 12.
9
Treatment of steroid-resistant pediatric nephrotic syndrome.儿童激素抵抗型肾病综合征的治疗
Korean J Pediatr. 2011 Aug;54(8):317-21. doi: 10.3345/kjp.2011.54.8.317. Epub 2011 Aug 31.
10
Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.利妥昔单抗治疗难治性和依赖性肾病综合征的疗效和安全性：多中心报告。
Clin J Am Soc Nephrol. 2010 Dec;5(12):2207-12. doi: 10.2215/CJN.03470410. Epub 2010 Aug 26.
利妥昔单抗（B细胞耗竭抗体）相关肺损伤（RALI）：1例儿科病例及文献系统综述
Pediatr Pulmonol. 2009 Sep;44(9):922-34. doi: 10.1002/ppul.20864.
4
Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.利妥昔单抗与静脉注射免疫球蛋白治疗慢性抗体介导的肾移植排斥反应
Transplantation. 2009 Jun 27;87(12):1837-41. doi: 10.1097/TP.0b013e3181a6bac5.
5
[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy.[18F]氟脱氧葡萄糖正电子发射断层扫描联合计算机断层扫描检测接受含利妥昔单抗化疗的非霍奇金淋巴瘤患者无症状性晚期肺毒性
Leuk Lymphoma. 2009 Jun;50(6):904-11. doi: 10.1080/10428190902919200.
6
Fatal pulmonary fibrosis after rituximab administration.利妥昔单抗给药后发生致命性肺纤维化。
Pediatr Nephrol. 2009 Sep;24(9):1753-5. doi: 10.1007/s00467-009-1195-9. Epub 2009 Apr 25.
7
Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients.静脉注射免疫球蛋白和利妥昔单抗成功治疗小儿肾移植受者的慢性抗体介导排斥反应。
Transplantation. 2008 Nov 15;86(9):1214-21. doi: 10.1097/TP.0b013e3181880b35.
8
Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.非霍奇金淋巴瘤含利妥昔单抗化疗期间的间质性肺炎
Leuk Lymphoma. 2008 Sep;49(9):1778-83. doi: 10.1080/10428190802270886.
9
Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.类风湿关节炎和系统性红斑狼疮中的抗CD20单克隆抗体
Handb Exp Pharmacol. 2008(181):163-81. doi: 10.1007/978-3-540-73259-4_8.
10
Rituximab-induced interstitial lung disease.利妥昔单抗诱导的间质性肺疾病。
Am J Hematol. 2007 Oct;82(10):916-9. doi: 10.1002/ajh.20910.